Table 2.
Univariable linear regression models for CMR EF1
| Coefficient | 95% CI | r2 | |
|---|---|---|---|
| Age per 10 years | − 0.08 | − 0.18, 0.02 | 0.02 |
| Male sex | 0.01 | − 0.24, 0.26 | 0.00 |
| Hypertension | − 0.15 | − 0.39, 0.10 | 0.01 |
| Ejection fraction (log2) | 0.43 | − 0.33, 1.19 | 0.01 |
| Mean gradient (log2) | − 0.47*** | − 0.60, − 0.33 | 0.26 |
| Left ventricular mass index (log2) | − 0.25 | − 0.59, 0.08 | 0.02 |
| Valvuloarterial compliance (log2) | − 0.36* | − 0.68, − 0.03 | 0.03 |
| Native T1 (log2) | − 1.23 | − 3.52, 1.05 | 0.01 |
| Extracellular volume fraction (log2) | 0.21 | − 0.66, 1.08 | 0.00 |
| Indexed extracellular volume (log2) | − 0.17 | − 0.46, 0.12 | 0.01 |
| Late gadolinium enhancement (any) | − 0.05 | − 0.29, 0.19 | 0.00 |
| Infarct late gadolinium enhancement (any) | − 0.12 | − 0.44, 0.21 | 0.00 |
| Global longitudinal strain (log2) | − 0.12 | − 0.37, 0.12 | 0.01 |
| High− sensitivity cardiac troponin I (log2) | − 0.05 | − 0.13, 0.02 | 0.01 |
| Brain natriuretic peptide (log2) | − 0.05 | − 0.12, 0.01 | 0.02 |
***p < 0.001; *p < 0.05